
SANS 2026: State-level rules and class action trends raise new stakes for supplement brands
Dietary supplement companies may be focused on FDA activity in Washington, but at the Sports & Active Nutrition Summit (SANS), Rend Al‑Mondhiry, partner at Amin Wasserman Gurnani LLP, warned that some of the major risks are emerging much closer to home.















































